Type 1 Diabetes CD56 NK Cells
Type 1 Diabetes CD56 NK Cells are cryopreserved from peripheral blood of IRB-consented adult donors diagnosed with Type 1 Diabetes. These CD56+ CD3− natural killer (NK) cells reflect disease-associated immune alterations and offer a critical resource for studying immune surveillance, inflammation, and cytotoxicity in the context of Type 1 Diabetes.
Product Specifications
Applications
Pre-clinical research, assay development, biomarker research, diagnostics, drug development, high-throughput screening, immune profiling
Assay Protocol
https://sanguinebio.com/wp-content/uploads/2023/08/Immune-Cell-Isolation.pdf
Shipping Conditions
-80C
Storage Conditions
-196°C
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1335269-01 0.02 mg (E-Coli)
Recombinant Pongo abelii Eukaryotic initiation factor 4A-II (EIF4A2)
Ask
View Details 
MBS1335269-02 0.02 mg (Yeast)
Recombinant Pongo abelii Eukaryotic initiation factor 4A-II (EIF4A2)
Ask
View Details 
MBS1335269-03 0.1 mg (E-Coli)
Recombinant Pongo abelii Eukaryotic initiation factor 4A-II (EIF4A2)
Ask
View Details MBS1335269-04 0.1 mg (Yeast)
Recombinant Pongo abelii Eukaryotic initiation factor 4A-II (EIF4A2)
Ask
View Details MBS1335269-05 0.02 mg (Baculovirus)
Recombinant Pongo abelii Eukaryotic initiation factor 4A-II (EIF4A2)
Ask
View Details MBS1335269-06 0.02 mg (Mammalian-Cell)
Recombinant Pongo abelii Eukaryotic initiation factor 4A-II (EIF4A2)
Ask
View Details